Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer

Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer

<b>Objective</b>: We evaluate the immunotherapeutic potential of the yellow fever virus vaccine strain 17D (YFV 17D) for intratumoral therapy of pancreatic cancer in mice. <b>Methods</b>: The cytopathic effect of YFV 17D on mouse syngeneic pancreatic cancers cells were studie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alina S. Nazarenko, Yulia K. Biryukova, Kirill N. Trachuk, Ekaterina A. Orlova, Mikhail F. Vorovitch, Nikolay B. Pestov, Nick A. Barlev, Anna I. Levaniuk, Ilya V. Gordeychuk, Alexander S. Lunin, Grigory A. Demyashkin, Petr V. Shegai, Andrei D. Kaprin, Aydar A. Ishmukhametov, Nadezhda M. Kolyasnikova
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Vaccines
Subjects:	virotherapy cancer immunotherapy 17D yellow fever vaccine intratumoral administration PDAC
Online Access:	https://www.mdpi.com/2076-393X/13/1/40
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intratumoral <i>Fusobacterium nucleatum</i> in Pancreatic Cancer: Current and Future Perspectives
by: Domenica Lucia D’Antonio, et al.
Published: (2024-12-01)

Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics
by: B.E. Nelson, et al.
Published: (2025-03-01)

Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
by: Binbin Liu, et al.
Published: (2025-01-01)

Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma
by: Ting Li, et al.
Published: (2025-01-01)

Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
by: Song Y, et al.
Published: (2025-01-01)

Investigating the role of intratumoral Streptococcus mitis in gastric cancer progression: insights into tumor microenvironment
by: Ping Yang, et al.
Published: (2025-01-01)

Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics
by: Lei Zhang, et al.
Published: (2025-02-01)

Intratumoral microbiota, fatty acid metabolism, and tumor microenvironment constitute an unresolved trinity in colon adenocarcinoma
by: Guangyi Liu, et al.
Published: (2025-01-01)

Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis
by: Fengle Jiang, et al.
Published: (2025-01-01)

The impact of innate immune response on the efficacy of oncolytic viruses
by: Kirill N. Trachuk, et al.
Published: (2024-12-01)

Intratumoral and peritumoral radiomics using multi-phase contrast-enhanced CT for diagnosis of renal oncocytoma and chromophobe renal cell carcinoma: a multicenter retrospective study
by: Yongsong Ye, et al.
Published: (2025-02-01)

Metagenomic and Transcriptomic Analysis Reveals Crosstalk Between Intratumor Mycobiome and Hosts in Early‐Stage Nonsmoking Lung Adenocarcinoma Patients
by: Yaohui Sun, et al.
Published: (2025-01-01)

Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation
by: Aline Talhouk, et al.
Published: (2025-01-01)

A comparative study of replicative properties of antitumor recombinant vaccinia viruses on human glioblastoma cell culture U87 and monkey kidney cell culture CV-1
by: R. A. Maksyutov, et al.
Published: (2017-02-01)

The replicability of oncolytic virus: Defining conditions in tumor virotherapy
by: Jianjun Paul Tian
Published: (2011-05-01)

RETRACTED: Parallel Encryption With Digit Arithmetic Of Covertext Model Using Duplicated Covertext
by: Hari Murti, et al.
Published: (2022-12-01)

Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
by: Joseph Malinzi, et al.
Published: (2018-11-01)

Zika virus has an oncolytic activity against human glioblastoma U87 cells
by: V. A. Svyatchenko, et al.
Published: (2019-01-01)

TIM‐4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL‐6 secretion
by: Ziyao Wang, et al.
Published: (2024-09-01)

TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC
by: Xiao-Mei Tang, et al.
Published: (2025-02-01)

Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell‐free RNA
by: Martin Metzenmacher, et al.
Published: (2025-02-01)

Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging
by: Xingrui Wang, et al.
Published: (2025-02-01)

Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
by: Qian Zhu, et al.
Published: (2025-01-01)

18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study
by: Jisce R. Puik, et al.
Published: (2025-01-01)

Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations
by: Alaa A. Abdelmageed, et al.
Published: (2024-12-01)

The role of TNF-α inhibitor in glioma virotherapy: A mathematical model
by: Elzbieta Ratajczyk, et al.
Published: (2016-12-01)

Most oncological pancreas resections must consider the mesopancreas
by: S. A. Safi, et al.
Published: (2025-02-01)

The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer
by: Danlei Ni, et al.
Published: (2025-01-01)

Genetic advancements in breast cancer treatment: a review
by: Marzieh Shokoohi, et al.
Published: (2025-02-01)

Improving systemic delivery of oncolytic virus by cellular carriers
by: Ziyi Peng, et al.
Published: (2024-12-01)

Selective epithelial expression of KRASG12D in the Oncopig pancreas drives ductal proliferation and desmoplasia that is accompanied by an immune response
by: Carlos P. Jara, et al.
Published: (2025-02-01)

Interactions between the tumor microbiota and breast cancer
by: Hua Guo
Published: (2025-01-01)

Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)
by: Pia Gattinger, et al.
Published: (2025-01-01)

Bifidobacterium animalis ssp. lactis BX-245-fermented milk alleviates tumor burden in mice with colorectal cancer
by: Chengcong Yang, et al.
Published: (2025-02-01)

Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
by: Peter S. Kim, et al.
Published: (2015-03-01)

Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
by: Joanna R. Wares, et al.
Published: (2015-07-01)

Advanced progress in the genetic modification of the oncolytic HSV-1 virus
by: Mi Zhou, et al.
Published: (2025-01-01)

Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
by: Soo Young Cho
Published: (2019-03-01)

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
by: Michael Ghadimi, et al.
Published: (2025-02-01)

Harnessing virtues for educational success: introducing the Positive Development and Assessment Competencies Theory (PDAC)
by: Pedro Vazquez-Marin, et al.
Published: (2025-01-01)